Thus, the aim of this study is to discuss the role of ghrelin signalling in colon carcinogenesis, diagnostics and CRC prognostics, and the potential use of ghrelin and its analogues in therapy of CRC-related syndromes (e.g., cachexia and sarcopenia). This evidence concerns the gene GHRL and colorectal carcinoma.